Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.145
+0.085 (2.78%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Arbutus Biopharma Employees
Arbutus Biopharma had 44 employees as of December 31, 2024. The number of employees decreased by 29 or -39.73% compared to the previous year.
Employees
44
Change (1Y)
-29
Growth (1Y)
-39.73%
Revenue / Employee
$140,250
Profits / Employee
-$1,589,091
Market Cap
603.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ABUS News
- 22 days ago - Arbutus Biopharma Cuts Workforce by More Than Half, Hires New CFO in Exec Shuffle - Market Watch
- 22 days ago - Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 weeks ago - Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna - GlobeNewsWire
- 7 weeks ago - Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO - GlobeNewsWire
- 2 months ago - Arbutus, Burford Capital, And Cadiz With Chris DeMuth Jr. - Seeking Alpha
- 3 months ago - Arbutus Provides 2025 Corporate and Financial Update - GlobeNewsWire
- 3 months ago - Arbutus: Positive Imdusiran Data Leads To Phase 2B Development - Seeking Alpha
- 4 months ago - Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors - Business Wire